- Unit 2 Marketing Processes and Planning (A/618/5033) Assignment Brief 2026
- TMDIBS204 Managing people in a Multinational Context Assignment Brief 2026
- BMS508 Entrepreneurship Assessment 2 Brief 2026 | New College Durham
- BMS508 Entrepreneurship Assessment 1 Brief 2026 | New College Durham
- BUS6010 Business Transformation Assessment Brief 2026 | Arden University
- Unit 805 Strategic Communication (L/506/9129) Assignment Brief 2026
- Unit 803 Strategic Planning for Cross Border and Global Organisations (L/506/9132) Assignment Brief 2026
- Unit 806 Culture and its Impact on Strategy (J/506/9128) Assignment Brief 2026
- Unit 800 Leadership Qualities and Practice (A/506/9126) Assignment Brief 2026
- EFAW301 Emergency First Aid in the Workplace (R/650/4839) Assignment Brief 2026
- SOCI5006 Popular Culture, Media and Society Assessment 1, 2026
- Resource Management in Health and Social Care (A/618/5503) Assignment Brief 2026
- Health and Safety in Health and Social Care Settings (T/618/5502) Assignment Brief 2026
- Principles of Leadership and Management (M/618/5501) Assignment Brief 2026
- Unit 601 Developing Personal Effectiveness and Impact Assignment Brief 2026
- OTHM Level 3 Diabetes Awareness (D/651/7162) Assignment Brief 2026
- OTHM Level 3 Health Promotion (A/651/7161) Assignment Brief 2026
- Personal and Professional Development in Health and Social Care (F/618/5499) Assignment Brief 2026
- Managing Quality in Health and Social Care Settings (K/618/5657) Assignment Brief 2026
- BAM4052 Finance for International Business Assignment Brief 2026
You are working within the pharmaceutical industry, and you have been assigned a kinase to develop an inhibitor for: Medicinal Chemistry Assignment, UniS, UK
| University | University Of Surrey (UniS) |
| Subject | Medicinal Chemistry |
You are working within the pharmaceutical industry, and you have been assigned a kinase to develop an inhibitor for. Your team has already found a compound that can moderate the activity of the kinase of interest.
- Using this information, use AutoDockTools and Autodock Vina to dock your compound with the kinase of interest. Your report should include
- A brief explanation of how you determine the search area for the docking, accompanied by a suitable picture to show where the search box is located with respect to the kinase in your docking.
You can click “Ligand Interaction” which will bring you to a new page displaying where and how a drug molecule interacts with the kinase. You can use your mouse to rotate and zoom in/out to help you visualize the binding site.
Once you have a good understanding of where the binding site should be, you need to adjust the dimensions, scaling factor, and the center of the search box in AutoDockTools based on this information. You need to make sure you define the search box correctly in your conf.txt file. - Description of possible interactions between your compound and the kinase that you have identified after docking, accompanied by a suitable picture and labeling to highlight the interactions.
- A table to show the binding affinity of your compound and the kinase from docking.
- Based on the results from the molecular docking, and also using your knowledge of medicinal chemistry, make FIVE changes you would make to the molecule in order to probe SAR and increase binding efficiency. Your answer should be a maximum of ONE A4 page in length, should concisely describe why you are making those changes, and should include chemical drawings of your hit compound and subsequent analogs in order to visualize those changes.
Buy Answer of This Assessment & Raise Your Grades
Answer



